To affirm the effect of O-GlcNAcylation on promoting progression of CCA cells, the consequences of increasing O-GlcNAcylation using PUGNAc (a well-known OGA inhibitor) were studied in one more CCA cell line, KKU-100. This evidence concerns the gene OGA and cholangiocarcinoma.